OLIVIA CICCARELLO: Open Payments
NPI 1144867946 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 51 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $239 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $198 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| PFIZER INC. | 4 | $80 |
| Sumitomo Pharma America, Inc. | 3 | $77 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| GENZYME CORPORATION | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| United Therapeutics Corporation | 2 | $44 |
| SHIELD THERAPEUTICS INC | 2 | $39 |
Products named: AIRSUPRA, Kerendia, TEZSPIRE, GEMTESA, DUPIXENT, FARXIGA, NURTEC ODT, Auvelity.
Industry payments across FL — which companies pay providers there.
